Atopic dermatitis (AD) is a chronic skin condition that predominantly manifests as inflamed, itchy, and dry skin. The pathway of atopic dermatitis involves a dysregulated immune response, leading to compromised skin barrier function, which makes the skin more susceptible to allergens, irritants and microbial invasion.
Atopic Skin vs. Eczema: Unraveling the Differences
While the terms “atopic skin” and “eczema” are often used interchangeably, they aren’t synonymous. Atopic dermatitis is a specific type of eczema, characterized by a particular genetic predisposition and immune response. Understanding these distinctions is crucial for accurate diagnosis and treatment, ensuring that those affected receive the most effective care.
Management, Not Cure: Navigating Atopic Dermatitis
Atopic dermatitis is currently not curable, but it is manageable. With advancements in dermatological research, patients can maintain healthy skin and reduce flare-ups through a combination of topical treatments, lifestyle changes, and supportive skincare routines. Understanding how to manage this condition effectively is vital for improving quality of life.
Market Insights: Atopic Dermatitis in the U.S.
Market Size and Growth
In the United States, the market for atopic dermatitis treatments is robust and growing. As of 2023, the market size was estimated at $10.7 billion, with projections to reach $18.2 billion by 2030. This growth is driven by the increasing prevalence of atopic dermatitis, particularly in children, and the ongoing innovation in treatment options.
Demographics and the Economic Burden
Atopic dermatitis affects approximately 15-20% of children and 1-3% of adults in the U.S., with a higher prevalence in urban areas and among certain ethnic groups. The economic burden is significant, with direct medical costs exceeding $5 billion annually, not to mention the impact of indirect costs such as lost productivity and diminished quality of life.
The Complex Nature of Atopic Skin: Disrupted Skin Barrier
The Itch-Scratch Cycle
One of the most challenging aspects of managing atopic dermatitis is the relentless itch-scratch cycle, which is a sensation with a reflex-like response. The nagging itching feeling sensation almost begins to feel like it won’t disappear until it’s scratched, leading to further barrier irritation and inflammation. And so, the cycle continues, the scratching exacerbates the skin’s barrier dysfunction, leading to further irritation and inflammation. Breaking this cycle is the key to effective management and improving quality of life.
Skin Microbiome and Environmental Factors
The skin microbiome plays a pivotal role in maintaining skin health. In atopic skin, there is often an imbalance, with an overgrowth of Staphylococcus aureus, which can exacerbate symptoms. Additionally, environmental factors such as pollution, climate, and allergens can trigger flare-ups, making a comprehensive treatment approach essential.
Current Treatment Options for Atopic Dermatitis
Prescription Medications
The treatment landscape for atopic dermatitis includes a range of prescription options, from topical corticosteroids to newer biologics like dupilumab. These treatments target specific pathways in the immune system, offering more precise management of symptoms.
Over-the-Counter (OTC) Products and the FDA Monograph
OTC products, including emollients and moisturizers, are vital for maintaining skin hydration and protecting the skin barrier. The FDA monograph for atopic dermatitis provides guidelines for ingredients that can be safely used in these formulations, ensuring that consumers have access to effective and safe products. Currently, the only ingredients that can successfully meet the monograph requirements are: Hydrocortisone (0.5-1%), Colloidal Oatmeal, Glycerin (20-45%), Zinc Oxide (1-25%), Petrolatum (30-100%) and Allantoin (0.5-2%). The last time the monograph was updated was 2003 and it is actively working to modernize and evaluate OTC monographs to better serve skin conditions, like atopic dermatitis.
These ingredients meet the current FDA’s strict guidelines for safety and efficacy when used in OTC products marketed for atopic dermatitis and itching relief. Formulating with these ingredients allows companies to make specific claims about their products’ ability to relieve symptoms associated with atopic dermatitis.
Cosmetics for Sensitive Skin
Cosmetics designed for sensitive skin are increasingly popular among those with atopic dermatitis. These products are formulated to be gentle and to avoid common irritants that can trigger flare-ups.
Ingredients to Avoid in Atopic Dermatitis Formulations
When formulating products for atopic dermatitis, it’s crucial to avoid ingredients that can further irritate or damage the skin. Common culprits include fragrances, harsh surfactants, and certain preservatives. A careful selection of ingredients is essential to create formulations that are both effective and safe.
Sytheon’s Active Expertise: Supporting Atopic Dermatitis Formulations
While there is no cure for Atopic Dermatitis, it can be managed by regulating skin barrier function. A damaged barrier causes the skin to lose moisture and creates an imbalance of lipids in the stratum corneum. Including ingredients that combat these factors can produce an effective formulation for managing atopic dermatitis.
Hydra Synol® DOI: Science and Pathway
Hydra Synol® DOI is a groundbreaking ingredient that helps restore the skin’s natural hydration mechanisms, promoting a healthier skin barrier. Its unique mode of action supports the skin’s moisture retention, making it an ideal component in formulations for atopic skin.
Decrease of CD-44, Aquaporin-3 and tight junction genes lead to dehydrated skin. Adding Hydra Synol® DOI into atopic dermatitis products can combat barrier dysfunction by upregulating these key genes and moving moisture to where it is most needed in the skin. CD-44, a gene that binds hyaluronic acid to cells, is a key molecule in water retention. Hydra Synol® DOI is able to upregulate this gene allowing more water to be retained in the skin. Lastly, Hydra Synol® DOI stimulates ceramide synthase-3 gene which promotes production of natural ceramides in the skin to create a balanced skin barrier.
Incorporating Hydra Synol® DOI into atopic dermatitis formulations offers a powerful solution for addressing skin barrier dysfunction and dehydration. By upregulating key genes like CD-44, Aquaporin-3, and ceramide synthase-3, it enhances the skin’s natural ability to retain moisture and strengthens the barrier. This unique mechanism helps restore hydration balance and promote healthier skin, making Hydra Synol® DOI an essential ingredient in developing effective treatments for atopic skin.
Synovea® EL: Targeting Inflammation, Skin Clarity and Skin Lipids
Synovea® EL is a powerful active that addresses the inflammatory pathways involved in atopic dermatitis. Its potent antioxidant properties help reduce oxidative stress, contributing to clearer and calmer skin.
Lipids are an essential part of regulating skin’s barrier and integrity. An imbalance of skin lipids in the stratum corneum are linked to Atopic Dermatitis appearing as inflammation and redness in the skin. Synovea® EL is a neutral, lipid-soluble stable form of linoleic acid, which is an essential fatty acid needed for skin nourishment. By converting to linoleic acid in the skin, Synovea® EL provides all the skin benefits to regulate and maintain barrier function. A study has shown that linoleic acid also contributes to reducing inflammatory responses in the skin.
By delivering a stable form of linoleic acid, Synovea® EL helps regulate the skin’s lipid balance and nourish it’s protective barrier. This lipid-soluble active supports the reduction of inflammation and redness, key symptoms of atopic dermatitis. Additionally, its antioxidant properties further protect the skin from oxidative stress, making Synovea® EL an essential component for soothing and maintaining healthier skin in atopic dermatitis formulations.
Asyntra® D-stress: Alleviating Stress-Induced Flare-Ups
Stress can have a direct correlation to triggering an atopic dermatitis flare-up. Anandamide is a key molecule that is part of the endocannabinoid system, one of our body’s defenses to fight stress. Asyntra® D-Stress maintains the level of Anandamides in our skin by inhibiting the enzymes caused by stress that degrade this molecule. In turn, cortisol levels and pro-inflammatory biomarkers are lowered leaving the skin less stressed and the barrier levels maintained. Two key ingredients in the Asyntra® D-Stress blend are Hydra Synol® DOI and Synovea® EL which contribute to regulating the skin’s barrier function.
Asyntra® D-stress is designed to mitigate the impact of stress on the skin, supporting a more balanced and resilient skin barrier.
Conclusion: Managing Atopic Skin with Innovative Formulations
Atopic skin presents unique challenges that require innovative solutions. While atopic dermatitis is not curable, effective management is achievable through a combination of targeted treatments and supportive skincare. There remains significant room for improvement in atopic formulations, with a growing demand for products that are not only medically effective but also cosmetically elegant. By integrating Sytheon’s cutting-edge actives, formulators can create products that meet these needs, promoting better outcomes and routine compliance.
Want to review this formula and get more information on Synastol® TC? Reach out to Sytheon at formulations@sytheonltd.com to speak with a formulator.